LENZ Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,101	794	-	-	-
Enterprise Value	914	578	-	-	-
Last Close Price	39.36	28.87	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Asset Turnover	0.02	-	-	0.46	-
Quick Ratio	20.27	20.09	3.55	4.68	14.61
Current Ratio	20.54	20.36	3.63	4.91	14.62
Return on Equity (ROE)	-26.25%	-38.94%	-157.61%	-39.80%	-
Return on Assets (ROA)	-18.44%	-25.64%	-77.17%	-20.07%	-
Return on Capital (ROIC)	-19.26%	-28.47%	-101.31%	-24.01%	-
Buyback Yield / Dilution	-222.30%	-986.27%	79.28%	-1.05%	-

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q